Get the Stockscreener App
44.88
4.06%
1.75
After Hours:
44.50
-0.38
-0.85%
Scholar Rock Holding Corp stock is traded at $44.88, with a volume of 947.01K.
It is up +4.06% in the last 24 hours and up +0.22% over the past month.
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.
See More
Previous Close:
$43.13
Open:
$43.17
24h Volume:
947.01K
Relative Volume:
0.88
Market Cap:
$4.20B
Revenue:
$47.30M
Net Income/Loss:
$-225.97M
P/E Ratio:
-19.10
EPS:
-2.35
Net Cash Flow:
$-188.86M
1W Performance:
+8.07%
1M Performance:
+0.22%
6M Performance:
+415.27%
1Y Performance:
+198.01%
1-Day Range:
$43.17
$45.26
1-Week Range:
$42.74
$45.26
52-Week Range:
$6.76
$46.19
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Name
Scholar Rock Holding Corp
Sector
Industry
Phone
857-259-3860
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
44.88 | 4.20B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-24 | Reiterated | H.C. Wainwright | Buy |
| Oct-07-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-24 | Initiated | Raymond James | Strong Buy |
| Oct-25-23 | Upgrade | Jefferies | Hold → Buy |
| Apr-03-23 | Resumed | Piper Sandler | Overweight |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Jul-12-22 | Initiated | Truist | Buy |
| Mar-23-22 | Initiated | H.C. Wainwright | Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-06-21 | Initiated | JP Morgan | Overweight |
| Mar-12-20 | Initiated | Robert W. Baird | Outperform |
View All
Scholar Rock Holding Corp Stock (SRRK) Latest News
Scholar Rock Holding Co. (NASDAQ:SRRK) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Scholar Rock CEO Jay Backstrom sells $985,951 in stock By Investing.com - Investing.com Australia
Scholar Rock CEO Jay Backstrom sells $985,951 in stock - Investing.com India
Scholar Rock's chief commercial officer sells $171,927 in common stock - MSN
Scholar Rock holding corp general counsel sells shares for $399,498 - MSN
Scholar Rock's chief scientific officer sells shares worth $324,716 - Investing.com
Scholar Rock's chief medical officer sells shares worth $249,935 - Investing.com
Scholar Rock's COO & CFO sells shares worth $554,188 - Investing.com
Scholar Rock's chief commercial officer sells $171,927 in common stock By Investing.com - Investing.com South Africa
Hamilton Lane Advisors LLC Acquires Shares of 29,478 Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock Holding Corporation Furnishes Presentation for J.P. Morgan Healthcare Conference - Defense World
Scholar Rock Holding (NASDAQ:SRRK) Stock Quotes, Forecast and News Summary - Benzinga
GAMMA Investing LLC Grows Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Here’s Why Scholar Rock Holding Corporation (SRRK) Is Skyrocketing - MSN
Is The Allstate Corporation (ALL) Among The Stocks That Could Surge From LA Wildfires Recovery Efforts? - Insider Monkey
Why These 24 Stocks Are Skyrocketing - Insider Monkey
Scholar Rock (NASDAQ:SRRK) Trading 5.8% HigherHere's Why - MarketBeat
Barclays PLC Cuts Position in Sturm, Ruger & Company, Inc. (NYSE:RGR) - Defense World
Jane Street Group LLC Buys Shares of 2,172 Freedom Holding Corp. (NASDAQ:FRHC) - Defense World
Barclays PLC Increases Stock Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Barclays PLC Has $1.32 Million Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock (NASDAQ:SRRK) Earns “Outperform” Rating from Wedbush - Defense World
Wedbush Reaffirms Outperform Rating for Scholar Rock (NASDAQ:SRRK) - MarketBeat
Scholar Rock Highlights 2025 Strategic Priorities - Business Wire
Scholar Rock (NASDAQ:SRRK) Stock Price Down 4.3%Should You Sell? - MarketBeat
Scholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Geode Capital Management LLC Has $12.36 Million Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Bought by Geode Capital Management LLC - MarketBeat
Barclays PLC Purchases 84,118 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Barclays PLC Has $1.32 Million Stake in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Given Average Rating of "Buy" by Brokerages - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Analyzing Scholar Rock (NASDAQ:SRRK) and 4D Molecular Therapeutics (NASDAQ:FDMT) - Defense World
Scholar Rock: Good Company, But This Ship Has Sailed - Seeking Alpha
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stock Holdings Lifted by Barclays PLC - Defense World
Scholar Rock: Likely Approval In SMA Plus Obesity Data In 2025 Intrigue, But Price Too High - Seeking Alpha
State Street Corp Sells 35,408 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
State Street Corp Reduces Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 6,269 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Stake Boosted by Wellington Management Group LLP - MarketBeat
Scholar Rock's SWOT analysis: biotech stock poised for pivotal trial results - Investing.com
BNP Paribas Financial Markets Boosts Stake in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Bought by BNP Paribas Financial Markets - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Scholar Rock Grants $9.5M in Equity Awards to Attract Top Talent in Strategic Growth Move - StockTitan
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Point72 Asset Management L.P. Increases Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
The Manufacturers Life Insurance Company Trims Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Certain Stock Options of Scholar Rock Holding Corporation are subject to a Lock-Up Agreement Ending on 8-DEC-2024. - Marketscreener.com
SRRK Stock Soars to 52-Week High, Hits $43.48 Amidst 146.5% Annual Surge By Investing.com - Investing.com South Africa
SRRK Stock Soars to 52-Week High, Hits $43.48 Amidst 146.5% Annual Surge - Investing.com Canada
Scholar Rock Holding Corp Stock (SRRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):